Who Supplies Gefitinib? Top Manufacturers & Their Global Buyers
India accounts for a significant share of global Gefitinib exports, with 80+ registered manufacturers shipping to buyers across 47+ countries — yet a handful of companies dominate the shipments. CIPLA LIMITED holds the largest share at 55.5% (export value: $3.8M). Close behind, NATCO PHARMA LIMITED (24.1%, $1.6M). JODAS EXPOIM PRIVATE LIMITED (5.8%, $390.6K). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
🏭 Market Analysis: Top Suppliers & Customer Networks
Comprehensive supplier network intelligence dashboard
Who Supplies Gefitinib? Top Manufacturers & Their Buyers
Flow of Gefitinib from leading Indian exporters to their key global customers
Supplier-Customer Network Analysis
Top Suppliers → Customer Networks
Gefitinib Supplier Network — Key Market Intelligence
The Gefitinib export market from India is led by CIPLA LIMITED, which alone commands a 55.5% share, shipping $3.8M worth of product across 21 shipments. The second-largest exporter, NATCO PHARMA LIMITED, contributes $1.6M (24.1%) to the overall market. Combined, the top two suppliers alone account for 79.5% of all Gefitinib exports, indicating a relatively concentrated supply base.
Across all 80 tracked manufacturers, the total Gefitinib export value stands at $6.8M from 297 shipments. The market average shipment value is $22.8K. The single largest buyer relationship in terms of trade value is THE MODERN CO, receiving $2.1M worth of product.
The combined buyer network spans 18 named purchasing companies, including THE MODERN CO, CIPLA BRASIL IMPORTADORA E DISTRIBUIDORA DE MEDICAMENTOS LTD, THE MODERN COMPANY F, CIPLA AUSTRALIA PTY , NATCOFARMA DO BRASIL LTDA, and 13 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Market Analysis: Top Suppliers & Their Customer Networks
1CIPLA LIMITED
CIPLA LIMITED is the first-largest Gefitinib exporter from India, with a market share of 55.5% and a total export value of $3.8M across 21 shipments. Their average shipment value of $178.9K is above the market average of $22.8K, suggesting premium or bulk contract pricing.
CIPLA LIMITED serves 5 named buyers in our database. THE MODERN CO is the dominant customer, accounting for 55.7% of this supplier's tracked business. Top customers include:
• THE MODERN CO — $2.1M across 12 shipments (55.7% of this supplier's total exports)
• CIPLA BRASIL IMPORTADORA E DISTRIBUIDORA DE MEDICAMENTOS LTD — $1.2M across 7 shipments (32.0% of this supplier's total exports)
• THE MODERN COMPANY F — $264.2K across 1 shipments (7.0% of this supplier's total exports)
• CIPLA BRASIL IMPORTADORA E DISTRIBUIDORA DE MEDICAMENTOS LTD — $138.5K across 1 shipments (3.7% of this supplier's total exports)
• CIPLA AUSTRALIA PTY — $59.6K across 0 shipments (1.6% of this supplier's total exports)
Key Insight: CIPLA LIMITED's per-shipment value of $178.9K is 684% above the market average of $22.8K, consistent with large-order contracts or value-added formulations.
2NATCO PHARMA LIMITED
NATCO PHARMA LIMITED is the second-largest Gefitinib exporter from India, with a market share of 24.1% and a total export value of $1.6M across 10 shipments. Their average shipment value of $163.1K is above the market average of $22.8K, suggesting premium or bulk contract pricing.
NATCO PHARMA LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• NATCOFARMA DO BRASIL LTDA, — $674.2K across 4 shipments (41.3% of this supplier's total exports)
• NATCOFARMA DO BRASIL LTDA, — $443.6K across 3 shipments (27.2% of this supplier's total exports)
• NATCOFARMA DO BRASIL LTDA, — $315.0K across 2 shipments (19.3% of this supplier's total exports)
• SOPHAL SPA — $144.4K across 1 shipments (8.9% of this supplier's total exports)
• SOUTH EGYPT DRUG IND — $53.6K across 0 shipments (3.3% of this supplier's total exports)
Key Insight: NATCO PHARMA LIMITED's per-shipment value of $163.1K is 615% above the market average of $22.8K, consistent with large-order contracts or value-added formulations.
3JODAS EXPOIM PRIVATE LIMITED
JODAS EXPOIM PRIVATE LIMITED is the third-largest Gefitinib exporter from India, with a market share of 5.8% and a total export value of $390.6K across 11 shipments. Their average shipment value of $35.5K is above the market average of $22.8K, suggesting premium or bulk contract pricing.
JODAS EXPOIM PRIVATE LIMITED serves 5 named buyers in our database. OOOJODAS EXPOIM is the dominant customer, accounting for 64.8% of this supplier's tracked business. Top customers include:
• OOOJODAS EXPOIM — $253.1K across 7 shipments (64.8% of this supplier's total exports)
• HATAY PHARMACEUTICAL — $111.9K across 3 shipments (28.6% of this supplier's total exports)
• SOFTCARE INTERNATION — $10.8K across 0 shipments (2.8% of this supplier's total exports)
• JS BANK LIMITED, — $10.5K across 0 shipments (2.7% of this supplier's total exports)
• SOFTCARE INTERNATION — $4.3K across 0 shipments (1.1% of this supplier's total exports)
Key Insight: JODAS EXPOIM PRIVATE LIMITED's per-shipment value of $35.5K is 56% above the market average of $22.8K, consistent with large-order contracts or value-added formulations.
4NAPROD LIFE SCIENCES PRIVATE LIMITED
NAPROD LIFE SCIENCES PRIVATE LIMITED is the fourth-largest Gefitinib exporter from India, with a market share of 2.3% and a total export value of $156.7K across 11 shipments. Their average shipment value of $14.2K is below the market average of $22.8K, reflecting a high-volume, competitive pricing strategy.
NAPROD LIFE SCIENCES PRIVATE LIMITED serves 3 named buyers in our database. NATCO LIFESCIENCES PHILIPPINES is the dominant customer, accounting for 91.1% of this supplier's tracked business. Top customers include:
• NATCO LIFESCIENCES PHILIPPINES — $142.8K across 10 shipments (91.1% of this supplier's total exports)
• DKM PHARMACEUTICALS — $10.3K across 1 shipments (6.6% of this supplier's total exports)
• DKM PHARMACEUTICALS — $3.6K across 0 shipments (2.3% of this supplier's total exports)
Key Insight: NAPROD LIFE SCIENCES PRIVATE LIMITED operates with high shipment frequency (11 shipments) at a per-shipment value of $14.2K, indicating a broad distribution network with many smaller, regular orders.
5KHANDELWAL LABORATORIES PRIVATE LIMITED
KHANDELWAL LABORATORIES PRIVATE LIMITED is the fifth-largest Gefitinib exporter from India, with a market share of 1.1% and a total export value of $72.4K across 11 shipments. Their average shipment value of $6.6K is below the market average of $22.8K, reflecting a high-volume, competitive pricing strategy.
KHANDELWAL LABORATORIES PRIVATE LIMITED serves 2 named buyers in our database. NI LAY NAING CO. LTD is the dominant customer, accounting for 67.5% of this supplier's tracked business. Top customers include:
• NI LAY NAING CO. LTD — $48.9K across 7 shipments (67.5% of this supplier's total exports)
• NI LAY NAING CO. LTD — $23.5K across 4 shipments (32.5% of this supplier's total exports)
Key Insight: KHANDELWAL LABORATORIES PRIVATE LIMITED operates with high shipment frequency (11 shipments) at a per-shipment value of $6.6K, indicating a broad distribution network with many smaller, regular orders.
6PROSPERA LIFE SCIENCES PRIVATE LIMITED
PROSPERA LIFE SCIENCES PRIVATE LIMITED is the fifth-largest Gefitinib exporter from India, with a market share of 0.4% and a total export value of $28.3K across 26 shipments. Their average shipment value of $1.1K is below the market average of $22.8K, reflecting a high-volume, competitive pricing strategy.
PROSPERA LIFE SCIENCES PRIVATE LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• MR. NORLADETH THAMMA — $11.3K across 10 shipments (40.1% of this supplier's total exports)
• MR. NORLADETH THAMMA — $7.4K across 7 shipments (26.2% of this supplier's total exports)
• STR INTERNATIONAL TR — $6.9K across 6 shipments (24.3% of this supplier's total exports)
• AS PER INVOICE — $1.5K across 1 shipments (5.2% of this supplier's total exports)
• AS PER INVOICE LAO P — $1.2K across 1 shipments (4.3% of this supplier's total exports)
Key Insight: PROSPERA LIFE SCIENCES PRIVATE LIMITED operates with high shipment frequency (26 shipments) at a per-shipment value of $1.1K, indicating a broad distribution network with many smaller, regular orders.
From Indian Factories to Global Pharmacies — How Gefitinib Flows
Once Gefitinib leaves the manufacturing plants of companies like CIPLA LIMITED and NATCO PHARMA LIMITED, it travels to 5 destination markets with a combined import value of $6.8M. Brazil absorbs the largest share at 41.7% ($2.8M), followed by Iraq (34.9%) and Philippines (5.5%).
In Brazil — the top destination — named importers include CIPLA BRASIL IMPORTADORA E, NATCOFARMA DO BRASIL LTDA, NATCOFARMA DO BRASIL LTDA,. In Iraq, key buyers are THE MODERN CO.
This geographic spread reflects Gefitinib's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
🌍 Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Where Does Gefitinib Go? Top Importing Countries & Their Buyers
Trade flow of Gefitinib exports from India — top destination countries and the named companies importing it
Geographic Market Flow Analysis
Top Countries → Global Importers
Market Analysis: Top Importing Countries & Their Importers
1Brazil
Brazil ranks as the first-largest destination for Gefitinib imports from India, with a total trade value of $2.8M across 15 shipments — representing a 41.7% share of all Gefitinib exports. The average shipment value of $188.1K is above the global average of $22.8K, indicating high-value procurement contracts or branded formulations. This market is served by 4 tracked buyers.
Named Gefitinib importers in Brazil: CIPLA BRASIL IMPORTADORA E is the largest buyer, accounting for 44.3% ($1.2M) of this market's total imports.
• CIPLA BRASIL IMPORTADORA E — $1.2M (44.3% of Brazil's total)
• NATCOFARMA DO BRASIL LTDA — $674.2K (23.9% of Brazil's total)
• NATCOFARMA DO BRASIL LTDA, — $443.6K (15.7% of Brazil's total)
Key Insight: Brazil's per-shipment average of $188.1K (725% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Brazil is a key market for Gefitinib imports from India.
2Iraq
Iraq ranks as the second-largest destination for Gefitinib imports from India, with a total trade value of $2.4M across 6 shipments — representing a 34.9% share of all Gefitinib exports. The average shipment value of $393.7K is above the global average of $22.8K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Gefitinib importers in Iraq: THE MODERN CO is the largest buyer, accounting for 88.5% ($2.1M) of this market's total imports.
• THE MODERN CO — $2.1M (88.5% of Iraq's total)
Key Insight: Iraq's per-shipment average of $393.7K (1627% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Iraq is a key market for Gefitinib imports from India.
3Philippines
Philippines ranks as the third-largest destination for Gefitinib imports from India, with a total trade value of $374.1K across 12 shipments — representing a 5.5% share of all Gefitinib exports. The average shipment value of $31.2K is above the global average of $22.8K, indicating high-value procurement contracts or branded formulations. This market is served by 3 tracked buyers.
Named Gefitinib importers in Philippines: NATCO LIFESCIENCES PHILLIPINES INC is the largest buyer, accounting for 45.6% ($170.6K) of this market's total imports.
• NATCO LIFESCIENCES PHILLIPINES INC — $170.6K (45.6% of Philippines's total)
• NATCO LIFESCIENCES PHILIPPINES — $142.8K (38.2% of Philippines's total)
• VE PHARMA INC. — $34.2K (9.1% of Philippines's total)
Key Insight: Philippines's per-shipment average of $31.2K (37% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Philippines is a key market for Gefitinib imports from India.
4Russia
Russia ranks as the fourth-largest destination for Gefitinib imports from India, with a total trade value of $253.1K across 2 shipments — representing a 3.7% share of all Gefitinib exports. The average shipment value of $126.5K is above the global average of $22.8K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Gefitinib importers in Russia: OOOJODAS EXPOIM is the largest buyer, accounting for 100.0% ($253.1K) of this market's total imports.
• OOOJODAS EXPOIM — $253.1K (100.0% of Russia's total)
Key Insight: Russia's per-shipment average of $126.5K (455% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Russia is a key market for Gefitinib imports from India.
5Myanmar
Myanmar ranks as the fifth-largest destination for Gefitinib imports from India, with a total trade value of $149.0K across 9 shipments — representing a 2.2% share of all Gefitinib exports. The average shipment value of $16.6K is below the global average of $22.8K, consistent with generic/API volume purchasing. This market is served by 2 tracked buyers.
Named Gefitinib importers in Myanmar: NI LAY NAING CO.LTD.. is the largest buyer, accounting for 45.2% ($67.4K) of this market's total imports.
• NI LAY NAING CO.LTD.. — $67.4K (45.2% of Myanmar's total)
• NI LAY NAING CO. LTD — $48.9K (32.8% of Myanmar's total)
Key Insight: Myanmar receives frequent, smaller shipments of Gefitinib — typical of markets with distributed retail pharmacy or hospital networks sourcing generics at volume.
Myanmar is a key market for Gefitinib imports from India.
People Also Ask — Gefitinib Supplier & Trade Network
Who are the top suppliers of Gefitinib from India?+
Which companies buy Gefitinib from Indian manufacturers?+
Where does Gefitinib exported from India go?+
What is the market share of the top Gefitinib supplier from India?+
What is the average shipment value for Gefitinib exports from India?+
Is Gefitinib manufactured in India and exported globally?+
Which country imports the most Gefitinib from India?+
Who are the buyers of Gefitinib in Iraq?+
How concentrated is the Gefitinib supplier market in India?+
How do I find verified buyers for Gefitinib in specific countries?+
Gefitinib Trade Network — Key Takeaways
- 1CIPLA LIMITED is India's dominant Gefitinib exporter with a 55.5% market share and $3.8M in total exports — making it the single most important sourcing entity in this market.
- 2The top 80 suppliers collectively account for 89.1% of all tracked Gefitinib exports, with a combined trade value of $6.8M.
- 3Brazil is the largest destination market, absorbing 41.7% of India's Gefitinib exports ($2.8M). Iraq (34.9%) and Philippines (5.5%) follow.
- 4With 297 total shipments averaging $22.8K each, the Gefitinib export trade from India reflects both bulk API supply and finished dosage form distribution.
- 5Verified buyers across the network include THE MODERN CO, CIPLA BRASIL IMPORTADORA E DISTRIBUIDORA DE MEDICAMENTOS LTD, NATCOFARMA DO BRASIL LTDA,, NATCOFARMA DO BRASIL LTDA, — representing a diverse base of pharmaceutical importers, distributors, and generic drug manufacturers globally.
Network Overview
Supplier Network
Country Network
Network Insights
Top supplier: 5 customers
6 suppliers → 47 countries
Network value: $6.8M
Related Analysis
Market Intelligence
Latest developments and market context
Detailed market intelligence for Gefitinib — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Gefitinib.
- 2.Flow Mapping: 80 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
- 3.Value Aggregation: Trade value per supplier-buyer link aggregated from 297 individual shipment records. Values are FOB in USD.
- 4.Geographic Clustering: Buyer networks clustered across 47 destination countries to identify geographic concentration patterns.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
297 Verified Shipments
80 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists